Claude Nicaise - Insider Trading & Ownership

Entity
Individual
Location
215 First Street, Suite 415, Cambridge, MA
Summary
The estimated net worth of Claude Nicaise is at least $2.46M dollars as of June 26, 2024. Claude Nicaise is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $2.29M. Claude Nicaise is the Director of CASSAVA SCIENCES INC and owns shares of CASSAVA SCIENCES INC (SAVA) stock worth about $169K.
All Insider Reports
All Insider Reports

Ownership of Claude Nicaise

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Director $2.29M Mar 1, 2024
SAVA CASSAVA SCIENCES INC Director $169K May 9, 2024
CMMB Chemomab Therapeutics Ltd. Director Mar 16, 2023
GANX Gain Therapeutics, Inc. Director Jun 24, 2024

Insider Transactions Reported by Claude Nicaise:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.